Human Tropical Fever IgG Lateral flow dipstick kit 7872

$487.00

Summary

Mikrogen diagnostik lateral flow device (dipstick) for research use (RUO)
Human Tropical Fever IgG Lateral flow dipstick kit 7872
Suitable for IgG detection
Ready-to-use
20 tests

SKU: 7872 Category: kits Tags: Chikungunya Virus, Dengue Virus, IgG, Lateral Flow Dipsticks, Tropical Fever, Zika Virus

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Human Tropical Fever (Chikungunya Virus, Dengue fever virus, Zikavirus) IgG
species reactivity	Chikungunya Virus, Dengue fever virus, Zikavirus
applications	Lateral flow (dipstick)
assay type	Indirect & qualitative
available sizes	20 test kits

Human Tropical Fever IgG Lateral flow dipstick kit 7872

Assay type
Sandwich assay, lateral flow (dipstick)

Research area
Infectious Disease

Sample type
Serum, plasma, whole blood

Components

10X Wash Buffer	100 mL
TMB Substrate	40 mL
Milk Powder	5 g
Instructions for Use	1 Each
Evaluation Form	1 Each
Test Strips	2 kits of [2 Vials x 10 Each]
Anti-Human IgG Conjugate	500 ?L
Positive Control	140 ?L
Negative Control	140 ?L

Storage
Store at 2-8°C.

Additional information
Mikrogen recomLine Tropical Fever Test

The Mikrogen recomLine Tropical Fever tests are serological, qualitative line immunoassays that combine the diagnostic markers Equad proteins and non-structural proteins (NS1), thereby enabling the identification of specific antibodies against the individual antigens of Dengue, Chikungunya, and Zika viruses. Virus-like particles (VLP) are used to detect CHIKV and NS1 and Equad proteins are used for DENV and ZIKV. The unique setup allows differentiation of DENV and ZIKV using a 2-step interpretation scheme that includes NS1 antigen reactions and, in their absence, reactivities against Equad proteins.

Advantages

New antigens: higher sensitivity due to CHIKV VLP, DENV and ZIKV Equad as well as improved flavivirus differentiation.
Simultaneous detection and differentiation of DENV, CHIKV, and ZIKV infections in one step.
Parallel detection of IgG and IgM enables monitoring of seroconversions and supports diagnosis of both primary and secondary flavivirus infections.
Additional diagnostic support to reliably exclude ZIKV infections in pregnant women.
For human serum/plasma from approximately 7 days after symptom onset and for follow-up samples after 1-2 weeks.
Easy and clear interpretation due to two-band criterion.
Partial and full automation, software-based evaluation (recomScan), and integration with the laboratory information system are possible.
High sensitivity and specificity due to the use of recombinant antigens.

Bands

Antigen Bands	Description
DENV NS1	Dengue non-structural protein 1 (1st stage differentiation)
DENV Equad	Variant d. dengue envelope protein with targeted mutations to increase specificity (2nd stage differentiation)
CHIKV VLP	Chikungunya virus-like particles
ZIKV NS1	Zika non-structural protein 1 (1st stage differentiation)
ZIKV Equad	Variant d. Zika envelope protein with targeted mutations to increase specificity (2nd stage differentiation)

target relevance
No information

Data

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.